56
Views
2
CrossRef citations to date
0
Altmetric
Review

Recent developments in therapeutics for prion diseases

Pages 35-59 | Published online: 18 Jan 2008
 

Abstract

Background: Conformational conversion of the normal prion protein PrPc into its pathogenic form, PrPSc, is the central event in the pathogenesis of prion diseases, including Creutzfeldt–Jakob disease in humans and bovine spongiform encephalopathy in cattle. This constitutive conversion results in accumulation of PrPSc in the brain and many lines of evidence indicate that the accumulated PrPSc may be detrimental, causing degenerative neuronal cell death. Objective: Therapeutic compounds for prion diseases must reduce PrPSc in affected brains. Many compounds have been identified to reduce PrPSc levels in infected cells and some were partially effective in infected animals, prolonging incubation or survival times. Clinical trials have only recently started with a few of these compounds. They are systematically introduced and their performances and possible mechanisms summarised. Methods: Bibliographic research was carried out using the PubMed database. Patent literature was searched using the UK Intellectual Property Office website. Results/conclusion: No compounds reported so far have proven to be therapeutically effective against prion diseases, due to inadequate access to brains through the blood–brain barrier. Moreover, due to lack of diagnostic indicators for presymptomatic individuals, the compounds must be given to clinically advanced patients, reducing their effectiveness. Thus, it is also important to resolve these problems to develop therapeutically effective compounds for prion diseases.

Acknowledgement

The author thanks K Murashita for figure preparations.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,757.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.